Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
insulin resistance7794 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A37065 | 16535923 | Recenti Prog Med | [Oxidative stress in metabolic syndrome and nonalcoholic steatohepatitis. Is it possible a role for vitamins in clinical practice?]. | 2006 | Details |
| A37068 | 16531962 | Ann Hepatol | Nonalcoholic steatohepatitis (NASH) with diabetes: predictors of liver fibrosis. | 2006 | Details |
| A37081 | 16672825 | J Clin Gastroenterol | Bariatric Surgery: A Promising Solution for Nonalcoholic Steatohepatitis in the Very Obese. | 2006 | Details |
| A37093 | 16492691 | J Clin Endocrinol Metab | Nonalcoholic steatohepatitis and nonalcoholic Fatty liver disease in young women with polycystic ovary syndrome. | 2006 | Details |
| A37102 | 16470923 | Zhejiang Da Xue Xue Bao Yi Xue Ban | [Nonalcoholic steatohepatitis in obese children: the prevalence and possible mechanism]. | 2006 | Details |
| A37130 | 16406828 | Mitochondrion | Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it. | 2006 | Details |
| A37180 | 16315634 | Rev Invest Clin | [Relationship between morphological diagnosis of NASH (non-alcoholic steatohepatitis) and liver function tests in a group of patients with morbid obesity]. | 2006 | Details |
| A37182 | 19079906 | Nutr Res Rev | Therapeutic potential of curcumin in non-alcoholic steatohepatitis. | 2005 | Details |
| A37197 | 16279898 | Am J Gastroenterol | Hypoadiponectinemia predicts the severity of hepatic fibrosis and pancreatic Beta-cell dysfunction in nondiabetic nonobese patients with nonalcoholic steatohepatitis. | 2005 | Details |
| A37246 | 16191492 | Endocr Pract | Polycystic ovary syndrome and severe nonalcoholic steatohepatitis: beneficial effect of modest weight loss and exercise on liver biopsy findings. | 2006 | Details |
| A37322 | 15959406 | Ann Endocrinol (Paris) | [Nonalcoholic steatohepatitis]. | 2005 | Details |
| A37330 | 15950075 | Arch Med Res | Hypomagnesemia, insulin resistance, and non-alcoholic steatohepatitis in obese subjects. | 2005 | Details |
| A37338 | 15922116 | Med Hypotheses | Acarbose is a promising therapeutic strategy for the treatment of patients with nonalcoholic steatohepatitis (NASH). | 2005 | Details |
| A37360 | 15868369 | J Gastroenterol | Metabolic aspects of hepatitis C viral infection: steatohepatitis resembling but distinct from NASH. | 2005 | Details |
| A37370 | 15842581 | Am J Gastroenterol | One-year intense nutritional counseling results in histological improvement in patients with non-alcoholic steatohepatitis: a pilot study. | 2005 | Details |
| A37374 | 15830293 | J Gastroenterol | Pediatric nonalcoholic steatohepatitis associated with hypopituitarism. | 2005 | Details |
| A37377 | 15828240 | Nihon Rinsho | [Role of PPARs in the pathophysiology of nonalcoholoic fatty liver disease]. | 2005 | Details |
| A37385 | 15800693 | Rom J Gastroenterol | The emerging problem of nonalcoholic steatohepatitis (NASH). | 2005 | Details |
| A37437 | 15682659 | Trop Gastroenterol | Prevalence of metabolic syndrome in non-diabetic and non-cirrhotic patients with non-alcoholic steatohepatitis. | 2005 | Details |
| A37456 | 15637751 | World J Gastroenterol | Nonalcoholic steatohepatitis in Asian Indians is neither associated with iron overload nor with HFE gene mutations. | 2005 | Details |
| A37463 | 15625656 | Clin Gastroenterol Hepatol | A pilot study of vitamin E versus vitamin E and pioglitazone for the treatment of nonalcoholic steatohepatitis. | 2004 | Details |
| A37465 | 15622489 | J Gastroenterol | Nonalcoholic steatohepatitis: cirrhosis, hepatocellular carcinoma, and burnt-out NASH. | 2004 | Details |
| A37484 | 15580405 | J Gastroenterol | Nonalcoholic steatohepatitis associated with psoriasis vulgaris. | 2004 | Details |
| A37487 | 15571584 | Am J Gastroenterol | A pilot trial of pentoxifylline in nonalcoholic steatohepatitis. | 2004 | Details |
| A37499 | 15554595 | Neth J Med | Nonalcoholic steatohepatitis. | 2004 | Details |
| A37543 | 15457967 | Ther Umsch | [Alcoholic and non-alcoholic steatohepatitis]. | 2004 | Details |
| A37549 | 15447754 | Am J Gastroenterol | Beneficial effects of tumor necrosis factor-alpha inhibition by pentoxifylline on clinical, biochemical, and metabolic parameters of patients with nonalcoholic steatohepatitis. | 2004 | Details |
| A37568 | 15343508 | Hum Pathol | Nonalcoholic steatohepatitis: histologic features and clinical correlations with 30 blinded biopsy specimens. | 2004 | Details |
| A37577 | 15331065 | Clin Liver Dis | Insulin resistance and the pathogenesis of nonalcoholic fatty liver disease. | 2004 | Details |
| A37595 | 15307867 | Am J Gastroenterol | Systemic levels of lipid peroxidation and its metabolic and dietary correlates in patients with nonalcoholic steatohepatitis. | 2004 | Details |
| A37611 | 15277442 | Diabetes Care | Approach to the pathogenesis and treatment of nonalcoholic steatohepatitis. | 2004 | Details |
| A37635 | 15223984 | Diabetes Metab | The ins and outs of mitochondrial dysfunction in NASH. | 2004 | Details |
| A37675 | 15142652 | Med Hypotheses | Aerobic exercise: a potential therapeutic intervention for patients with liver disease. | 2004 | Details |
| A37691 | 15106708 | Indian J Gastroenterol | Assessment of insulin resistance and effect of metformin in nonalcoholic steatohepatitis--a preliminary report. | 2004 | Details |
| A37708 | 15066643 | Eur J Intern Med | Non-alcoholic steatohepatitis: review of a growing medical problem. | 2004 | Details |
| A37737 | 14985228 | Am J Clin Nutr | Model of nonalcoholic steatohepatitis. | 2004 | Details |
| A37753 | 14752837 | Hepatology | A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis. | 2004 | Details |
| A37773 | 14687831 | Am J Gastroenterol | Does leptin play a role in the pathogenesis of human nonalcoholic steatohepatitis? | 2003 | Details |
| A37835 | 14512888 | Hepatology | Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-gamma ligand rosiglitazone. | 2003 | Details |
| A37836 | 14512887 | Hepatology | Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis. | 2003 | Details |
| A37841 | 14502318 | Rom J Gastroenterol | The effects of sibutramine and orlistat on the ultrasonographic findings, insulin resistance and liver enzyme levels in obese patients with non-alcoholic steatohepatitis. | 2003 | Details |
| A37868 | 12907343 | Am J Gastroenterol | Metabolic and anthropometric evaluation of insulin resistance in nondiabetic patients with nonalcoholic steatohepatitis. | 2003 | Details |
| A37895 | 12836490 | Acta Clin Belg | Nonalcoholic steatohepatitis and insulin resistance: interface between gastroenterologists and endocrinologists. | 2003 | Details |
| A37897 | 12830008 | Hepatology | Hepatic gene expression in histologically progressive nonalcoholic steatohepatitis. | 2003 | Details |
| A37942 | 12717402 | Hepatology | Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. | 2003 | Details |
| A37959 | 12668986 | Hepatology | Dietary habits and their relations to insulin resistance and postprandial lipemia in nonalcoholic steatohepatitis. | 2003 | Details |
| A37963 | 12663234 | J Hepatol | Interim results of a pilot study demonstrating the early effects of the PPAR-gamma ligand rosiglitazone on insulin sensitivity, aminotransferases, hepatic steatosis and body weight in patients with non-alcoholic steatohepatitis. | 2003 | Details |
| A37985 | 12601351 | Hepatology | Hepatic cytochrome P450 2E1 activity in nondiabetic patients with nonalcoholic steatohepatitis. | 2003 | Details |
| A38041 | 12425538 | Am J Gastroenterol | Nonalcoholic steatohepatitis: what we know in the new millennium. | 2002 | Details |
| A38083 | 12197781 | Altern Med Rev | Nonalcoholic fatty liver disease: relationship to insulin sensitivity and oxidative stress. Treatment approaches using vitamin E, magnesium, and betaine. | 2002 | Details |
| A38101 | 12143049 | Hepatology | Serum leptin in NASH correlates with hepatic steatosis but not fibrosis: a manifestation of lipotoxicity? | 2002 | Details |
| A38116 | 12105842 | Gastroenterology | Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. | 2002 | Details |
| A38159 | 12016549 | Semin Liver Dis | Drugs and steatohepatitis. | 2002 | Details |
| A38179 | 11965828 | Int J Clin Pract Suppl | Thiazolidinedione hepatotoxicity: a class effect? | 2000 | Details |
| A38184 | 11950797 | Gut | Non-alcoholic steatohepatitis (NASH): where are we now and where are we going? | 2002 | Details |
| A38186 | 11944630 | Semin Gastrointest Dis | Diabetes mellitus, obesity, and hepatic steatosis. | 2002 | Details |
| A38220 | 11873108 | J Clin Gastroenterol | Update on nonalcoholic fatty liver disease. | 2002 | Details |
| A38231 | 11826411 | Hepatology | NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome. | 2002 | Details |
| A38232 | 11826410 | Hepatology | Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association. | 2002 | Details |
| A38233 | 11825539 | Curr Gastroenterol Rep | Evolving pathophysiologic concepts in nonalcoholic steatohepatitis. | 2002 | Details |
| A38248 | 11768156 | Lipids | Postprandial triglyceride-rich lipoprotein metabolism and insulin sensitivity in nonalcoholic steatohepatitis patients. | 2001 | Details |
| A38284 | 11693332 | Am J Gastroenterol | Ninety patients with nonalcoholic steatohepatitis: insulin resistance, familial tendency, and severity of disease. | 2001 | Details |
| A38336 | 11513189 | Am J Gastroenterol | Hyperferritinemia, iron overload, and multiple metabolic alterations identify patients at risk for nonalcoholic steatohepatitis. | 2001 | Details |
| A38395 | 11349722 | Transplantation | Lipoatrophic diabetes and end-stage liver disease secondary to nonalcoholic steatohepatitis with recurrence after liver transplantation. | 2001 | Details |
| A38417 | 11296694 | Semin Liver Dis | Etiopathogenesis of nonalcoholic steatohepatitis. | 2001 | Details |
| A38431 | 11266382 | Gastroenterology | Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. | 2001 | Details |
| A38659 | 10634920 | Clin Nutr | Non-alcoholic fatty liver: another feature of the metabolic syndrome? | 1999 | Details |
| A38697 | 10545713 | Dig Dis | Fatty liver and nonalcoholic steatohepatitis. Where do we stand and where are we going? | 1999 | Details |
| A38701 | 10535879 | Gastroenterology | Insulin resistance-associated hepatic iron overload. | 1999 | Details |
| A42234 | 35146047 | Open Forum Infect Dis | Metabolic-Associated Fatty Liver Disease Is Highly Prevalent in the Postacute COVID Syndrome. | 2022 | Details |
| A42236 | 35127953 | J Diabetes Res | Metabolic (Dysfunction)-Associated Fatty Liver Disease in Chinese Patients with Type 2 Diabetes from a Subcenter of the National Metabolic Management Center. | 2022 | Details |
| A42243 | 35115401 | Proc Natl Acad Sci U S A | Cullin neddylation inhibitor attenuates hyperglycemia by enhancing hepatic insulin signaling through insulin receptor substrate stabilization. | 2022 | Details |
| A42246 | 35106852 | Phytother Res | A systematic review and meta-analysis of preclinical and clinical studies on the efficacy of ginger for the treatment of fatty liver disease. | 2022 | Details |
| A42261 | 35047117 | World J Diabetes | Omics era in type 2 diabetes: From childhood to adulthood. | 2021 | Details |
| A42263 | 35046902 | Front Endocrinol (Lausanne) | Molecular and Cellular Bases of Lipodystrophy Syndromes. | 2022 | Details |
| A42274 | 35022960 | Mol Cell Biochem | Autophagy: a molecular switch to regulate adipogenesis and lipolysis. | 2022 | Details |
| A42286 | 34981780 | J Clin Invest | Do endocannabinoids acting via hepatic CB-1 contribute to NAFLD and hepatic insulin resistance? | 2022 | Details |
| A42287 | 34979132 | J Hepatol | Metabolic and genetic contributions to NAFLD: Really distinct and homogeneous? | 2021 | Details |
| A42291 | 34957482 | Diabetes | Hepatic P38 Activation Modulates Systemic Metabolism Through Fgf21-Mediated Interorgan Communication. | 2021 | Details |
| A42332 | 34847647 | Diabetes Metab J | Albuminuria Is Associated with Steatosis Burden in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease (Diabetes Metab J 2021;45:698-707). | 2021 | Details |
| A42333 | 34847645 | Diabetes Metab J | Albuminuria Is Associated with Steatosis Burden in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease (Diabetes Metab J 2021;45:698-707). | 2021 | Details |
| A42337 | 34825869 | Curr Drug Metab | Regulatory Effects of N-3 PUFAs on Pancreatic β-cells and Insulin-sensitive Tissues. | 2021 | Details |
| A42359 | 34767670 | Biofactors | Vitamin D3 enhances the effects of omega-3 oils against metabolic dysfunction-associated fatty liver disease in rat. | 2021 | Details |
| A42389 | 34698347 | Clin Infect Dis | Evolution of Fatty Liver Disease and Relationship With Lipoproteins and Clinical Outcomes in Hepatitis B/Human Immunodeficiency Virus Coinfection. | 2022 | Details |
| A42390 | 34697893 | J Dig Dis | Multidisciplinary participation: The key to a cure for non-alcoholic fatty liver disease. | 2021 | Details |
| A42392 | 34689140 | Horm Res Paediatr | Genetic Obesity in Children: Overview of Possible Diagnoses with a Focus on SH2B1 Deletion. | 2021 | Details |
| A42395 | 34675006 | Diabetes | Hepatic P38 Activation Modulates Systemic Metabolism Through Fgf21-Mediated Interorgan Communication. | 2021 | Details |
| A42407 | 34618686 | J Clin Invest | Inhibiting serotonin signaling through HTR2B in visceral adipose tissue improves obesity-related insulin resistance. | 2021 | Details |
| A42421 | 34572340 | Biomedicines | Short-Term SGLT2 Inhibitor Administration Does Not Alter Systemic Insulin Clearance in Type 2 Diabetes. | 2021 | Details |
| A42422 | 34572325 | Biomedicines | Glycomacropeptide for Management of Insulin Resistance and Liver Metabolic Perturbations. | 2021 | Details |
| A42423 | 34564583 | Vet Sci | Imipramine Accelerates Nonalcoholic Fatty Liver Disease, Renal Impairment, Diabetic Retinopathy, Insulin Resistance, and Urinary Chromium Loss in Obese Mice. | 2021 | Details |
| A42430 | 34542351 | Crit Rev Food Sci Nutr | Branched chain amino acids-friend or foe in the control of energy substrate turnover and insulin sensitivity? | 2021 | Details |
| A42441 | 34511811 | J Clin Exp Hepatol | Lean Fatty Liver Disease: Through Thick and Thin. | 2021 | Details |
| A42452 | 34503598 | J Dev Orig Health Dis | Metabolic programming in offspring of mice fed fructose during pregnancy and lactation. | 2021 | Details |
| A42462 | 34474907 | Am J Cardiol | Independent Association of Fatty Liver Index With Left Ventricular Diastolic Dysfunction in Subjects Without Medication. | 2021 | Details |
| A42469 | 34455076 | Pharmacol Res | The pivotal role of Nrf2 activators in adipocyte biology. | 2021 | Details |
| A42470 | 34449134 | Obesity (Silver Spring) | Salmon peptides limit obesity-associated metabolic disorders by modulating a gut-liver axis in vitamin D-deficient mice. | 2021 | Details |
| A42476 | 34439969 | Biology (Basel) | Aldehyde Dehydrogenase Mutation Exacerbated High-Fat-Diet-Induced Nonalcoholic Fatty Liver Disease with Gut Microbiota Remodeling in Male Mice. | 2021 | Details |
| A42480 | 34425095 | Gastroenterology | Hepatic miR-144 Drives Fumarase Activity Preventing NRF2 Activation During Obesity. | 2021 | Details |
| A42487 | 34402268 | Zhongguo Zhong Yao Za Zhi | [Efficacy and mechanism of new resource medicinal materia Moringa oleifera leaves against hyperlipidemia]. | 2021 | Details |